Latest filing published 01 Dec 2025 for Pasithea Therapeutics Corp., €17k.
No signal scores available.
Daniel H. Schneiderman is a declared insider at 2 companies; the most frequent names are MetaStat, Inc. and Pasithea Therapeutics Corp. Between 14 October 2014 and 28 November 2025, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 1 December 2025, reports a share grant of €17k in Pasithea Therapeutics Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations